Abstract
AimsTo (1) reclassify ocular adnexal large B-cell lymphomas (OA-LBCLs) per 2016 WHO lymphoma classification and (2) determine the prevalence of MYD88 and CD79B mutations and their association with clinical parameters...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have